Market News

Honda Motor Adr (HMC) Stock Declined While Cardinal Capital Management Cut Its Stake; As Merck & Co (MRK) Share Price Declined, Cadence Capital Management Lowered by $716,464 Its Position

Merck & Co., Inc. (NYSE:MRK) Logo

Amy Minella decreased its stake in Honda Motor Adr (HMC) by 14.76% based on its latest 2017Q4 regulatory filing with the SEC. Cardinal Capital Management sold 10,136 shares as the company’s stock declined 1.66% with the market. The hedge fund run by Amy Minella held 58,541 shares of the capital goods company at the end of 2017Q4, valued at $2.00M, down from 68,677 at the end of the previous reported quarter. Cardinal Capital Management who had been investing in Honda Motor Adr for a number of months, seems to be less bullish one the $58.76B market cap company. The stock decreased 1.33% or $0.44 during the last trading session, reaching $32.87. About 216,731 shares traded. Honda Motor Co., Ltd. (NYSE:HMC) has risen 9.48% since May 15, 2017 and is uptrending. It has underperformed by 2.07% the S&P500.

Cadence Capital Management Llc decreased its stake in Merck & Co Inc (MRK) by 6.24% based on its latest 2017Q4 regulatory filing with the SEC. Cadence Capital Management Llc sold 12,794 shares as the company’s stock declined 4.63% with the market. The institutional investor held 192,314 shares of the health care company at the end of 2017Q4, valued at $10.82M, down from 205,108 at the end of the previous reported quarter. Cadence Capital Management Llc who had been investing in Merck & Co Inc for a number of months, seems to be less bullish one the $159.48B market cap company. The stock decreased 0.67% or $0.401 during the last trading session, reaching $59.279. About 2.32 million shares traded. Merck & Co., Inc. (NYSE:MRK) has declined 14.94% since May 15, 2017 and is downtrending. It has underperformed by 26.49% the S&P500.

More notable recent Honda Motor Co., Ltd. (NYSE:HMC) news were published by: Seekingalpha.com which released: “Meet the electric/autonomous vehicle ETF” on April 17, 2018, also Nasdaq.com with their article: “Ford’s Sales Slip Again as Sedan Sales Dwindle” published on May 03, 2018, 247Wallst.com published: “Ford Sales Expected to Suffer in April” on April 28, 2018. More interesting news about Honda Motor Co., Ltd. (NYSE:HMC) were released by: 247Wallst.com and their article: “Ford F-Series Easily Tops April Pickup Sales” published on May 01, 2018 as well as Fool.com‘s news article titled: “Forget What Wall Street Says, Polaris Industries Is Looking Good” with publication date: May 07, 2018.

Among 9 analysts covering Honda Motor Co (NYSE:HMC), 2 have Buy rating, 5 Sell and 2 Hold. Therefore 22% are positive. Honda Motor Co had 22 analyst reports since August 27, 2015 according to SRatingsIntel. Jefferies upgraded the shares of HMC in report on Friday, February 26 to “Buy” rating. As per Tuesday, December 22, the company rating was initiated by Susquehanna. The stock of Honda Motor Co., Ltd. (NYSE:HMC) has “Neutral” rating given on Tuesday, May 31 by Bank of America. Macquarie Research downgraded the shares of HMC in report on Thursday, December 1 to “Neutral” rating. The firm has “Buy” rating given on Monday, May 29 by Jefferies. Jefferies maintained it with “Buy” rating and $34.55 target in Monday, September 18 report. The rating was maintained by Jefferies on Wednesday, April 11 with “Buy”. The firm has “Hold” rating by Jefferies given on Friday, October 9. The firm has “Outperform” rating given on Saturday, February 4 by Macquarie Research. The company was downgraded on Friday, May 13 by Credit Agricole.

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on July, 27. They expect $1.04 EPS, up 2.97% or $0.03 from last year’s $1.01 per share. MRK’s profit will be $2.80 billion for 14.25 P/E if the $1.04 EPS becomes a reality. After $1.05 actual EPS reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts -0.95% negative EPS growth.

Cadence Capital Management Llc, which manages about $4.62 billion and $1.57B US Long portfolio, upped its stake in Patrick Inds Inc (NASDAQ:PATK) by 13,367 shares to 36,346 shares, valued at $2.52M in 2017Q4, according to the filing. It also increased its holding in Enova Intl Inc by 53,670 shares in the quarter, for a total of 129,664 shares, and has risen its stake in Sucampo Pharmaceuticals Inc (NASDAQ:SCMP).

More notable recent Merck & Co., Inc. (NYSE:MRK) news were published by: Seekingalpha.com which released: “Merck Is Inexpensive – Cramer’s Lightning Round (5/7/18)” on May 08, 2018, also Seekingalpha.com with their article: “New Ebola outbreak hits Congo” published on May 13, 2018, 247Wallst.com published: “What to Look For in the Merck and Pfizer Reports Tuesday Morning” on April 30, 2018. More interesting news about Merck & Co., Inc. (NYSE:MRK) were released by: Benzinga.com and their article: “Keytruda Is Key To The Merck Thesis, Goldman Sachs Says In Upgrade” published on April 23, 2018 as well as Seekingalpha.com‘s news article titled: “Merck: Getting Stronger” with publication date: May 04, 2018.

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 21 have Buy rating, 0 Sell and 3 Hold. Therefore 88% are positive. Merck & Co. Inc. had 90 analyst reports since August 13, 2015 according to SRatingsIntel. Guggenheim upgraded Merck & Co., Inc. (NYSE:MRK) on Thursday, January 12 to “Buy” rating. As per Friday, March 23, the company rating was maintained by Jefferies. The stock has “Neutral” rating by Credit Suisse on Monday, May 9. The firm has “Buy” rating by UBS given on Monday, October 30. BMO Capital Markets maintained the stock with “Outperform” rating in Thursday, October 12 report. The rating was maintained by Bank of America on Tuesday, November 28 with “Buy”. The rating was maintained by Piper Jaffray on Friday, July 28 with “Buy”. DZ Bank upgraded the stock to “Buy” rating in Tuesday, February 13 report. The company was maintained on Monday, July 31 by UBS. On Tuesday, November 17 the stock rating was maintained by Argus Research with “Buy”.

Investors sentiment decreased to 0.94 in Q4 2017. Its down 0.12, from 1.06 in 2017Q3. It worsened, as 94 investors sold MRK shares while 631 reduced holdings. 123 funds opened positions while 558 raised stakes. 1.93 billion shares or 1.34% less from 1.96 billion shares in 2017Q3 were reported. Old Point Trust And Finance Svcs N A has 1.03% invested in Merck & Co., Inc. (NYSE:MRK). Jfs Wealth Limited Liability Corporation holds 9,328 shares. Lombard Odier Asset Mgmt (Europe) Ltd has invested 0.11% in Merck & Co., Inc. (NYSE:MRK). Kempner Mgmt holds 65,886 shares. Shelton Cap Management stated it has 0.19% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Tudor Invest Et Al holds 17,793 shares or 0.03% of its portfolio. Park National Corporation Oh accumulated 410,749 shares. Jpmorgan Chase & holds 0.4% or 33.48 million shares. Spectrum Asset Management Inc (Nb Ca), a California-based fund reported 3,575 shares. Smith Salley & Associates reported 94,186 shares. National Asset Management invested 0.36% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Texas-based Moody Comml Bank Trust Division has invested 0.07% in Merck & Co., Inc. (NYSE:MRK). Neville Rodie & Shaw Incorporated invested in 281,573 shares. 53,951 were accumulated by Advisor Ptnrs Lc. Portland Global Advsr reported 16,215 shares or 0.34% of all its holdings.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *